We have used the polymerase chain reaction technique to clone the small multiply spliced mRNA species produced after infection of human cells by a molecular clone of human immunodeficiency virus type 1 (HIV-1). We identified six Rev-expressing mRNAs, which were generated by the use of two splice acceptors located immediately upstream of the rev AUG. The class of small mRNAs included 12 mRNAs expressing Tat, Rev, and Nef. In addition, HIV-1 produced other multiply spliced mRNAs that used alternative splice sites identified by cloning and sequencing. All of these mRNAs were found in the cytoplasm and should be able to produce additional proteins. The coding capacity of the tat, rev, and nef mRNAs was analyzed by transfection of the cloned cDNAs into human cells. The tat mRNAs produced high levels of Tat, but very low levels of Rev and Nef. All the rev mRNAs expressed high levels of both Rev and Nef and were essential for the production of sufficient amounts of Rev. Therefore, HIV-1 uses both alternatively spliced and bicistronic mRNAs for the production of Tat, Rev, and Nef proteins.
located in exon 7 (antisense strand). The locations of the amplification primers are indicated in Fig. 1 . The sequences and the exact positions of the primers in the HXB2 genome are as follows: NARS, 5'-CTCTAGCAGTGGCGCCCGAA CAGGG-3' (nt 173 to 197); BSS, 5'-GGCTTGCTGAAGCG CGCACGGCAAGAGG-3' (nt 246 to 273); SACS, 5'-GAAG AAGCGGAGACAGCGACGAAGAGCTC-3' (nt 5523 to 5551); 3016S, 5'-TCATCAAGCTTCTCTATCAAAGCAGT-3' (nt 5568 to 5593); 3423A, 5'-CATCATCGCCCTCTTACT ATTACCTC-3' (nt 6195 to 6220); 3015A, 5'-CTGAAACG ATAATGGTGAATATCC-3' (nt 7901 to 7924); and BAMA, 5'-GCCAAGGATCCGTTCACTAATCGAATGG-3' (nt 8004 to 8031). The primer pair BSS-BAMA was used for amplification of all small multiply spliced mRNAs, primer pairs 3016S-BAMA and SACS-3015A were used to amplify cDNAs containing the exon 4 to 7 splice junction, and primer pair NARS-3423A was used to amplify cDNAs containing exon 6D.
Oligonucleotides used as probes were located in exon 2 (EXON2S), the intron between exons 2 and 3 (IN), exon 3 (EXON3S), exon 4 (2606S), exon 4A/4B (CO12), exon 5 (SACS) (see above), and exon 6D (3311). The sequences and the positions of these oligonucleotides are as follows: EXON2S, 5'-GGACCAGCAAAGCTCCTCTG-3' (nt 4484 to 4503); IN, 5'-CACATCCCACTAGGGGATGC-3' (nt 4752 to 4771); EXON3S, 5'-GGACACATAGTTAGCCCTAGG-3' (nt 4962 to 4982); 2606S, 5'-GGTGTCGACATAGCAGAA TAGGC-3' (nt 5329 to 5351); C012, 5'-CTTAGGCATCTC CTATGGCA-3' (nt 5502 to 5521); and 3311, 5'-TTCACGTG ACTAAACTTCTTACTATGATTATGG-3' (nt 6158 to 6190). The numbering system follows the corrected HXB2 sequence (44, 49, 50, 51; Pavlakis, unpublished) , where +1 is the mRNA start site. cDNA synthesis and PCR amplification. Total RNA (0.2 to 1 ,ug) was reverse transcribed in the presence of the antisense oligonucleotide primer, and the resulting DNA was amplified in the same tube as follows. The RNA was heated at 65°C for 5 min and cooled on ice. First-strand synthesis of cDNA was carried out in a total volume of 100 ,ul containing 50 mM KCI, 10 NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS). Immunoprecipitations were carried out with rabbit preimmune (P), anti-Tat (T), anti-Rev (R), and anti-Nef (N) antisera and analyzed on 15% denaturing polyacrylamide gels as described before (Felber et al., submitted) .
Western immunoblots. The transfected cells were lysed in 0.5x RIPA buffer 2 days after transfection. Proteins were separated on SDS-polyacrylamide gels and transferred to nitrocellulose filters. The filters were probed with HIV-1 patient sera followed by "25I-labeled protein A as described before (28) . RESULTS cDNA synthesis and amplification. To investigate the structure of the small multiply spliced HIV-1 mRNAs, we amplified cDNAs from HIV-1-infected or -transfected cells by PCR. The locations of the PCR primers used to amplify cDNAs corresponding to the small mRNAs are indicated in Fig. 1C . First, cDNA was synthesized by using reverse transcriptase and the primer BAMA, located in exon 7 at the 3' part of the provirus. (The numbering system of exons used herein follows that of Muesing et al. [42] with modifications.) The synthesized cDNAs were subsequently PCR-amplified in the same tube with the same primer in combination with primer BSS, located in exon 1 (Fig. 1) . Primers in exons 1 and 7 were selected, since these exons are presumably present in all the viral transcripts. In order to distinguish cDNAs differing in size by only a few nucleotides, the VOL. 64, 1990 on October 19, 2017 Southern blot analysis. To verify that these amplified products represented HIV cDNAs and to identify the genomic regions they contained, the amplified cDNAs were transferred to nylon membranes and hybridized to different probes located in exons 2, 3, 4, or 5 and to the intron between exons 2 and 3 ( Fig. 2 ). These exons have been shown to be present in various small HIV-1 mRNAs (4, 42).
All bands visualized by ethidium bromide staining hybridized to the exon 1 and exon 7 probes (data not shown), as well as to an exon 5 probe (Fig. 2) , indicating that this region in exon 5 is present in all small multiply spliced HIV-1 mRNAs. Amplification products detected by hybridization to two different probes within exon 4 are also shown. Probe 4 hybridized to a region upstream of the tat AUG and probe 4AB hybridized to a region spanning the rev AUG. Interestingly, probe 4AB hybridized to many more bands than probe 4, indicating the existence of at least one splice site located after the tat AUG but before the rev AUG. Hybridization with probes in exons 2 and 3 showed that these small, noncoding exons were present in many cDNAs. We also used a probe located between exons 2 and 3, named IN. This probe should hybridize to an mRNA containing exon 2A ( Fig. 1) , which may form mRNAs expressing Vif protein (4). analysis (54) . This proposed splice acceptor corresponds to 4B, identified here by cDNA cloning and sequencing. We also cloned and sequenced cDNAs corresponding to the previously described tat mRNAs containing exon 4 (4, 42) . These three variant mRNAs are designated here as 1.4.7, 1.2.4.7, and 1.3.4.7, according to the exons they contain (Fig. 3) . Sequence analysis of clones containing exon 5 confirmed and extended previous studies, which had identified two exon 5-containing mRNAs, 1.5.7 and 1.2.5.7 (4, 42) . In line with observations made for the tat and rev mRNAs, the group of mRNAs containing exon 5 was also found to consist of three mRNAs (Fig. 3) , generated by splicing of exon (Fig. 3B) , resulting in additional mRNAs. The assignment of some bands is shown on the right. results suggested that the unidentified cDNA bands represent cytoplasmic mRNAs.
Identification of additional HIV splice sites. To obtain more information about the additional multiply spliced mRNAs, we focused our attention on the region between exons 4 and 7. We have recently identified another small exon, named exon 6D, located within the env gene, as indicated in Fig. 3 . We have shown that one mRNA containing exons 1, 4, 6D, and 7 generates a hybrid protein, Tev (7), consisting of the first exon of Tat, 38 amino acids of Env, and the second exon of Rev. We reasoned that this exon might be spliced not only to exon 4 but also to exons, 5, 4A, and 4B. This could generate a maximum of 12 additional mRNAs, differing from the mRNAs depicted in Fig. 3 only by the presence of exon 6D spliced to exon 7. To test this hypothesis, we synthesized a primer located in exon 6D (primer 3423A, Fig. 1C ). This primer was used for cDNA synthesis of RNA isolated from HXB2-infected or -transfected cells and subsequent PCR amplification in combination with the NARS primer located in exon 1. The cDNAs were subjected to Southern blot analysis with probes located in exon 4, 4A/4B, or 5 (Fig. 4) . These experiments demonstrated that exon 6D was spliced to exon 4, 4A, 4B, or 5, indicating that at least 4 and possibly 12 mRNAs containing exon 6D exist in HXB2-infected cells. The similar results obtained in amplifications with BSS-BAMA and NARS-3423A indicated that mRNAs containing the small exons 2 and 3 in addition to 6D were also produced. The presence of exon 6D-containing mRNAs can partially account for the additional unassigned bands detected in Fig.  2 . The structures and coding potential of four of these mRNAs (1.4.6D.7, 1.4A.6D.7, 1.4B.6D.7, and 1.5.6D.7) are shown in Fig. 3B . It has been shown that HIV-1-infected cells produce Tev from 1.4.6D.7 mRNA (7) and that a protein containing 20 amino acids of Env linked to the second exon of Rev can be produced from 1.4A.6D.7, 1.4B.6D.7, or 1.5.6D.7 mRNAs (7).
To identify any additional splice sites between the splice donor utilized by exons 4, 4A, 4B, and 5 and the splice acceptor of exon 7 (nt 5591 to 7925, Fig. 1 ), we PCRamplified mRNAs containing this region with two primers, 3016S and 3015A, designed to detect alternative splice sites. Primer 3016S extends 4 nt 3' of the splice donor at nt 5591 (Fig. 1) , and primer 3015A extends 25 nt 5' of the exon 7 splice acceptor at nt 7925, thereby selectively amplifying either unspliced or alternatively spliced mRNAs in this region. cDNA synthesis and PCR amplification with primer pair 3016S and BAMA did not result in amplification products corresponding to alternatively spliced mRNAs, indicating that only the previously described splice donor at nt 5591 (Fig. iB) was utilized in this region. Sequence analysis of cDNAs amplified with primers SACS and 3015A revealed that this splice donor could be spliced to two additional splice acceptors, located upstream of the exon 7 splice acceptor (nt 7925). The corresponding exons were designated 7A and 7B ( Fig. 1 and 7 In order to identify other alternatively spliced small mRNAs, we replica-plated several hundred colonies from the cDNA library and screened them with probes 2, 3, 4, 4AB, and 5. Using this approach, we did not identify any additional cDNAs. We were also unable to find any mRNA species containing both exons 2 and 3, indicating that exons 2 and 3 are mutually exclusive within the multiply spliced mRNAs. In addition, no cDNAs containing exons 1, 2, or 3 linked directly to exon 7 were found. Results of colony hybridizations with oligonucleotide 3015A as a probe revealed that exon 7A and 7B splice acceptors were present in less than 1% of the cDNA clones, which indicates that these splice acceptors are rarely used by the virus.
Protein production by the cDNA clones. The coding potential of the various cDNAs was examined by gene transfer experiments. In order to express individual cDNAs in HeLa cells, they were transferred into eucaryotic expression vectors that provided the HIV-1 LTR promoter and polyadenylation site (see Materials and Methods). This strategy resulted in eucaryotic expression vectors producing authentic HIV-1 mRNAs without missing or extraneous nucleotides. Figure 5A shows the results obtained after transfection of one cDNA expression plasmid from each group (i.e., pNL1.5.7, pNL1.4A.7, or pNL1.4.7; see Fig. 3 ) into HLtat cells, a HeLa cell line constitutively expressing the first exon of the HIV-1 Tat protein (Felber et al., submitted) . Protein products were biosynthetically labeled and immunoprecipitated with anti-Tat (T), anti-Rev (R), or anti-Nef (N) antisera (Fig. 5A) . These experiments showed that pNL1.5.7 produced Nef, while pNL1.4A.7 produced high levels of both Rev and Nef. The expression of Rev and Nef from plasmid pNL1.4B.7 was similar to that from pNL1.4A.7 (data not shown). pNL1.4.7 produced high levels of the 16-kDa twoexon Tat protein. Expression of low levels of Rev and Nef from pNL1.4.7 could only be detected in very long exposures of these gels. To exclude the possibility that the expressed mRNAs were further spliced after transfections, RNA from cells transfected with the various cDNA expression plasmids was isolated and PCR-amplified as described above with primers BSS and BAMA. No evidence of splicing was detected in these experiments (data not shown), verifying that the same mRNA molecule produced more than one protein.
The effect of the presence of the small exons 2 and 3 on the expression of cDNAs was examined by comparing the levels of Nef protein expressed by the three nef cDNAs, which differ only in the presence or absence of exons 2 or 3 (Fig.  SB) expression to a similar extent in these cells, suggesting that high levels of functional Tat protein were produced from all cDNAs. As expected, vectors expressing rev or nef cDNAs were unable to activate cat expression, since they all lack an intact tat gene (data not shown).
To assay for Rev function, we transfected the cDNA expression plasmids into HLfB cells (Mermer et al., in press), which contain stably integrated copies of a rev mutant molecular clone of HIV-1. These cells produced low levels ofp55gag and Env proteins (Fig. 6, lane 7) , but did not process p55gag to p24gag and pl7gag and did not produce virus particles. As shown in lane 1 of Fig. 6 , complementation by Rev protein after transfection of the Rev-producing plasmid pL3crev resulted in an increased production of p55gag and Env proteins, as well as the production of p24gag and p179ag. We used this complementation assay to study the expression of Rev protein by the different cDNAs. Both pNL1.4B.7 and pNL1.4A.7 were able to complement the rev defect in HLfB cells (Fig. 6, lanes 3 and 4, respectively) , indicating production of high levels of functional Rev protein. All six different 4A-or 4B-containing cDNAs complemented equally well (data not shown). Transfection of pNL1.4.7, which contains both tat and rev overlapping reading frames, resulted in very low levels of complementation (lanes 5 and 6). When 15 ,ug of plasmid pNL1.4.7 was used in the transfection (lane 5) instead of 5 Fg (lane 6), higher levels of p24gag and Env proteins were detected, indicating that low levels of Rev protein are produced from the tat mRNAs. However, these levels were too low to fully restore the wild-type phenotype of the rev mutant provirus in HLfB cells. Therefore, efficient production of Rev requires the presence of the rev-specific mRNAs. As expected, Nef-producing pNL1. produced from 12 mRNAs. Each protein is produced from a group of mRNAs consisting of at least three mRNAs differing in the leader sequence preceding the coding exons. This is a result of splicing to the small noncoding exons 2 and 3, located in the 5' part of the virus (Fig. 1) . Structural and functional assays did not reveal any significant difference between the Tat-expressing cDNAs or between the Rev-or the Nef-expressing cDNAs. These results differ from those of Muesing et al. (43) , who reported that 1.3.4.7 tat cDNA transactivated the HIV-1 LTR five times better than 1.4.7 cDNA.
The splice acceptors of exons 2 and 3, at positions 4459 and 4936, respectively, are apparently utilized to produce mRNAs encoding Vif and Vpr proteins. The predicted structures of the vif and vpr mRNAs are shown in Fig. 3B . The production of these mRNAs could potentially decrease the levels of expression of the proteins encoded downstream of vif and vpr, e.g., tat, rev, vpu, env, and nef. A possible role for the splicing with the splice donors defining exons 2 and 3 might be the production of high levels of mRNAs expressing these downstream proteins. In this regard, it is noteworthy that mRNAs containing exons similar to 2 and 3 in HIV-1 are produced by other lentiviruses such as SIVMAC (9) and visna virus (11) .
Four new splice sites were identified by cloning and sequencing, and the corresponding exons were named 4A, 4B, 7A, and 7B. The 5' splice sites generating exons 4A and 4B are positioned only six nucleotides apart, after the tat AUG and before the rev AUG. Thus, utilization of either splice acceptor 4A or 4B allows expression of rev but not tat. A similar mechanism to generate rev mRNA(s) has been proposed for the SIVMAC virus isolate by Colombini et al. (9) . These investigators identified a cDNA clone that uses a splice acceptor between the tat and rev AUGs and is believed to represent the Rev-producing mRNA. The observation that cDNAs containing exon 4A or 4B were cloned with the same frequency after PCR amplification indicates similar use of both splice acceptors. In addition, direct detection of exons 4A and 4B in infected or transfected cells by Si nuclease analysis revealed similar levels of mRNAs (Felber et al., submitted) . Although the purpose of using two splice acceptors in this region is unclear, it is noteworthy that both splice acceptors are conserved among different HIV-1 isolates (Fig. 7) . In addition, the splice acceptor 4A is also well conserved in the distantly related lentiviruses HIV-2 and SIV. (Fig. 7) . Although the biological significance of these mRNAs remains to be investigated, it is noteworthy that an alternative splice acceptor has also been found in the last exon of the SIVMAC genome (64) . This further underlines the similar organization of the lentiviruses.
Although the splice sites producing exon 6D are not conserved in all HIV strains, it is interesting that this exon was present in many small multiply spliced mRNAs. This observation indicates that the generation of one splice site might result in many new alternatively spliced mRNAs. This might be an additional mechanism by which lentiviruses diverge at a high rate. Exons 6D, 7A, and 7B could generate several different mRNAs by alternative splicing. Assuming that exon 6D could be spliced to all 12 mRNA species reported here, a total number of 24 differentially spliced small mRNAs would be generated. Furthermore, if the splice acceptors for exons 7A and 7B are utilized in addition to exon 7, a total of 72 differentially spliced small HIV-1 mRNAs would be generated. We have previously shown that one of the 6D-containing mRNAs produces a hybrid protein, Tev (7). The protein products of other exon 6D-containing mRNAs have also been studied (7) . Although the significance of these mRNA species for the virus remains to be determined, identification of the alternative splice sites further underlines the complexity of HIV-1 splicing. The acquisition of regulatory factors such as Rev, which allows the production of appropriate quantities of structural mRNAs, may have allowed the incorporation of additional splice signals and the generation of many alternatively spliced mRNAs. Alternative splicing may offer an evolutionary advantage to the virus, since proteins are produced from more than one mRNA. Also, the plasticity of the genome may allow new combinations to arise and enable viral adaptation to a new environment.
Results of the functional studies of the HIV-1 cDNA clones shown in Fig. 5 and 6 and summarized in Table 1 revealed that tat mRNAs produced very low levels of Rev and Nef, while rev mRNAs produced high levels of both Rev and Nef proteins. These data are in agreement with the scanning model for initiation of translation (34, 35) , according to which the ribosome binds at the 5' end of the mRNA and scans the RNA for a suitable initiation site. Initiation at the tat AUG appears to be very efficient, allowing the ribosome to read the downstream AUGs for rev and nefonly in rare instances. This results in high production of Tat but only low production of Rev and Nef (Fig. 5A) . In contrast, the rev AUG seems to allow readthrough of the ribosome to a much higher degree than the tat AUG, resulting in high levels of both Nef and Rev proteins expressed from the rev mRNAs (Fig. SA) .
Since tat mRNAs are very poor producers of Rev protein, specific rev mRNAs containing exon 4A or 4B are essential for production of sufficient amounts of Rev. Rev produced from mRNAs containing either exon 4A or 4B was sufficient to restore virus expression from the rev mutant provirus integrated in HLfB cells (Fig. 6 ). These data are in disagreement with the results presented by Sadaie et al. (54) , who reported that a derivative of HXB2 containing a point mutation at the exon 4B splice site displayed a rev mutant phenotype after transfection into COS cells (mutant M43 [54] ). Our data show that HXB2 can generate another equally potent rev mRNA by using the adjacent splice acceptor, 4A. Therefore, mutant M43 should also produce Rev. Accordingly, we were able to show that M43 produced functional levels of Rev protein by using the complementation assay described above (data not shown). We also were able to immunoprecipitate Rev from M43-transfected HeLa cells. We concluded that M43 is a rev-deficient but not rev-minus mutant.
The multiply spliced mRNAs lack the RRE element and are present in high levels in the absence of Rev (17, 28) . The cloning and characterization of the majority, if not all, of the multiply spliced HIV-1 mRNAs allowed the generation of specific probes for the study of the expression of the individual species by S1 nuclease analysis (Felber et We have shown that HIV-1 produces one group of mRNAs for each regulatory protein Tat, Rev, and Nef, presumably allowing high levels of expression of each of these proteins by the virus. It is interesting that the Nef protein is produced in high amounts from its own group of three monocistronic mRNAs as well as from the six bicistronic rev mRNAs. Although HIV-1 produces several bicistronic mRNAs, it does not depend on the expression of more than one protein from each of the mRNAs producing Tat, Rev, and Nef. This is unlike the organization of the human T-cell leukemia viruses (45) , which are proposed to rely on a single doubly spliced mRNA for the production of both Tax and Rex regulatory proteins.
